Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$127.59 - $203.08 $31,897 - $50,770
-250 Reduced 8.2%
2,800 $566,000
Q4 2022

Feb 14, 2023

BUY
$117.37 - $139.17 $88,027 - $104,377
750 Added 32.61%
3,050 $391,000
Q3 2022

Oct 26, 2022

BUY
$135.27 - $180.11 $60,871 - $81,049
450 Added 24.32%
2,300 $314,000
Q4 2021

Feb 14, 2022

BUY
$142.57 - $190.86 $263,754 - $353,091
1,850 New
1,850 $286,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.